Blog Archives

Roche’s Rituxan Cures Rare Skin-Blistering Disease in Study

Roche Holding AG (ROG)’s top-selling drug Rituxan effectively cured most cases of a rare and deadly skin disease in a patient study that suggests the medicine may replace steroids as the standard treatment. In a trial among 22 people with

Tagged with: , , , , , , , ,
Posted in Around the Globe, News and Information, Treatment and Medication

Enteric-coated mycophenolate sodium as a steroid-sparing agent in pemphigus treatment: a retrospective study

Several immunosuppressive drugs are used as steroid-sparing agents in pemphigus vulgaris (PV) treatment, with the aim of reducing the cumulative dose of steroids and minimizing the side effects of long-term steroid treatment. Opening Grasshopper this proscar hair loss odor scent

Tagged with: ,
Posted in Clinical Research

Azathioprine in the treatment of Autoimmune Blistering diseases

Although there are no standard guidelines for the treatment of autoimmune blistering diseases, azathioprine has shown good efficacy in acquired autoimmune blistering diseases, and is well tolerated. Side effects of azathioprine normally occur in mild variants. Severe reactions are due

Tagged with: , , ,
Posted in Around the Globe
The P/P Registry has been approved by the Western Institutional Review Board (WIRB) and is actively enrolling participants.